India-based CRO SIRO Clinpharm formed a strategic alliance with Cambridge Regulatory Services, a full-service regulatory consultancy for the pharmaceutical industry. The companies claim their partnership will provide clients with a one -stop, cost-effective solution for accessing expertise in clinical trials and drug registration.


“Our alliance with CambReg will go a long way in helping small- and mid-sized companies cut through the regulatory maze in Europe,” says Chetan Tamhankar, Ph.D., SIRO Clinpharm’s COO.


Karen James, M.D., at Cambridge Regulatory Services, adds, “The partnership will provide European pharma companies with increased confidence in accessing cost-effective clinical trials solutions, hence introducing new clients to SIRO. In return, SIRO will have the benefit of offering regulatory expertise through CamReg.”








This site uses Akismet to reduce spam. Learn how your comment data is processed.